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ABSTRACT
Background: Dermatomyositis is an idiopathic, inflammatory/immunemediated disease of the skin, muscles and blood 
vessels of hereditary nature and unclear pathogenesis. This familial disease has been described in certain breeds, especially 
collies and Shetland sheep dogs and is of rare occurrence in mongrel dogs. To describe and discuss three clinical cases of 
dermatomyositis-like disease and provide a brief review of the literature.
Cases: Three young mongrel dogs are included in this report. Case 1: Mandarino, a 4-year-old mongrel dog, having a 
history of skin lesions for at least a year. Showed an underweight patient, skin ulcers, crusts, alopecia, peri-ocular scarring 
causing severe lagophthalmia and a corneal ulcer. Muscle atrophy was most notable in the head and legs; the dog had 
difficulty and pain walking. Treatment was initialised with cephalexin 30 mg/kg BID, pentoxifylline 25 mg/kg BID, and 
prednisone 2.2 mg/kg SID. The patient was presented after two weeks for follow up; the anaemia and skin condition had 
improved, the weight had increased by 2 kg, dysphagia and locomotor abnormalities were not present. Case 2: Milagros, 
a mongrel female dog approximately two years of age, rescued from a shelter. Physical examination showed facial alope-
cia, erythema and scarring of the periocular skin, crusting and scaling in alopecic areas, pinnae tip necrosis and crusting, 
ear alopecia, tail tip necrosis and crusting. Also present were distal limb alopecia, crusting and ulcers in areas of trauma 
in the hock and carpal surfaces; some nails presented onychorhexis and onychoschizia. The patient has been treated for 
12 months with a good clinical outcome, with pentoxifylline, azathioprine 2.2 mg/kg EOD alternating with prednisone 1 
mg/kg EOD. Case 3: Chuchito, an 11-month-old male mongrel rescued dog had been previously hospitalised due to his 
skin condition. Physical examination showed depigmented and alopecic areas in the nasal planum, perioral and periocular 
areas, and inflammation of the palpebral tissues. Necrosis of the distal pinnae, alopecia and scales were evident, along with 
sloughing of scales and ulcers. Skin lesions were also present in the distal limbs, and alopecia, erythema and some crusting 
and scales in the carpal, tarsal and digital areas. Onychodystrophy was present in several digits. This study describes the 
physical examination and the clinical pathological findings, including skin scrapings, fungal cultures, and skin biopsies, in 
three dogs with dermatomyositis-like disease, as well as the clinical outcomes after slightly different treatment protocols 
were used. The biopsy results of two dogs showed ischaemic dermatopathy.
Discussion: The most common initial signs of the disease are erythema, desquamation and alopecia in the facial area, 
ears, distal limbs and pinnae in young puppies aged between two and six months of age, followed by pigmentary changes. 
Muscular lesions are uncommon; when present, they represent the most severe form of this disease. Dysphagia is a com-
mon sign and mega-oesophagus may be present. Patients with muscular disease can manifest difficulty walking, with a 
stiff high gait. The immune mediated pathogenesis of dermatomyositis can relate to triggering factors in some dogs, such 
as drugs, infections, paraneoplasms, or toxins. Other potential inducing stressors include oestrus, whelping and excessive 
solar exposure. Dermatomyositis-like or familiar dermatomyositis is diagnosed using clinical findings, histopathology 
of skin and muscle, and muscle physiology studies. Electromyography, breed predisposition and genetic background 
can be helpful in some cases. The clinical findings and response to the treatment of all three cases were compatible with 
dermatomyositis-like disease in mongrel dogs.
Keywords: dermatomyositis, dermatopathy, vascular disease, inflammatory myopathies, mongrel dog.
2G. García, C. Romero, G. Sheinberg, et al. 2018. Three Cases of Canine Dermatomyositis-Like Disease.                                                       
Acta Scientiae Veterinariae. 46(Suppl 1): 276.
INTRODUCCTION
Canine dermatomyositis is an uncommon skin 
disease that may affect muscles and vascular tissues 
[5,8]. Familial canine dermatomyositis (DM) is a he-
reditary idiopathic condition of the skin and muscles of 
young collies, Shetland, Beauceron, Belgian Tervuren 
and Portuguese water dogs; it has also been reported in 
the mongrel dog (familial canine dermatomyositis). A 
similar syndrome called dermatomyositis-like disease 
has also been also described in a Pembroke Welsh 
corgi, Lakeland terrier, Chow Chow, Jack Russell ter-
rier, German shepherd dog, Kuvasz, and in mongrels 
[4,6,10,16,17] and a Rottweiler [2].
Dermatomyositis is believed to be a vascular 
disease; in general, vascular diseases seem to be as-
sociated with an immunologic response that damages 
vascular components of the dermis and subcutane-
ous tissues. Cutaneous vasculitis may be associated 
with coexisting diseases, such as malignancies, drug 
reactions or connective tissue disorders [7]. In dogs, 
ischaemic dermatopathies include five subtypes: 
canine familial dermatomyositis; juvenile-onset isch-
aemic dermatopathy; focal post-rabies vaccination 
reaction; generalised vaccination-induced ischaemic 
dermatopathy; and adult-onset generalised ischaemic 
dermatopathy [13].
Pentoxifylline may not be sufficient to control 
the disease and the use of steroids might be necessary, 
such as prednisone and triamcinolone, or a combination 
of other drugs. Topical steroids, or tacrolimus 0.1% 
twice daily, might also help to control localised lesions.
CASES
Case 1. Mandarino, a 4-year-old mongrel dog 
was presented to the dermatology service, having a 
history of skin lesions for at least a year since it was 
rescued. He had aprevious diagnosis of ichthyosis, 
scabies and demodicosis, and was previously treated 
with different antibiotics for several weeks. He had also 
received weekly ivermectin subcutaneous injections 
(unknown dose and trademark) and chlorhexidine (un-
know trademark) baths, with no clinical improvement.
No treatment was being administered at the 
time of presentation. The owner reported anorexia, 
dysphagia and a mild cough. Physical examination 
showed an underweight patient, skin ulcers, crusts, 
alopecia, scarring of the peri-oral muscles and skin 
causing exposure of the teeth and gums, peri-ocular 
scarring causing severe lagophthalmia and a corneal 
ulcer affecting the left eye (Figure 1A). Muscle atrophy 
was most notable in the head and legs; the dog had dif-
ficulty and pain walking. Also present were necrosis of 
the pinnae (Figure 1B), ulceration and alopecia of the 
tail and skin of the distal limbs (Figure 1C); the abdo-
men and prepuce was also affected (Figure 1D). There 
were crackling sounds on auscultation, no fever was 
detected, the patient was uncomfortable and in pain.
Skin scrapings were negative for mites, cytol-
ogy showed evidence of secondary bacterial infection, 
a fungal culture was negative after 21 days. Thoracic 
radiographs were performed and an alveolar pattern 
in the ventral aspect of the right middle lung lobe 
was present, consistent with aspiration pneumonia. A 
complete blood count showed non-regenerative anae-
mia and neutrophilia with the presence of immature 
neutrophils; the blood chemistry revealed raised levels 
of total proteins and globulins. Biopsies were taken 
from muscle and different skin lesions; histopathology 
revealed no relevant changes in the muscle. Dermato-
pathology showed follicular atrophy, dermal fibrosis, 
interstitial infiltrate of mononuclear cells, hydropic 
degeneration of the epidermal basal layer and changes 
compatible with vascular disease.
Figure 1. Muscle atrophy in the head and legs (A), necrosis of the pin-
nae (B), ulceration and alopecia   (C), the abdomen and prepuce was also 
affected (D).
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Treatment was initialised with cephalexin 
(Keflex®)1 30 mg/kg BID, pentoxifylline (Elorgan®)2 
25 mg/kg BID, and prednisone (Meticorten®)3 2.2 mg/
kg SID. Eye lubrication and medical therapy for the 
left eye ulcer was also instituted.
The patient was presented after two weeks for 
follow up; the anaemia and skin condition had im-
proved, the weight had increased by 2 kg, dysphagia 
and locomotor abnormalities were not present.
Ten weeks after initiating treatment, the patient 
started showing changes related to steroid therapy 
(marked polydipsia and polyuria); consequently, the 
prednisone was tapered slowly to 1mg/kg but clini-
cal signs continued and lesions started to reappear. 
Therapy with azathioprine (Imuran®)4 was instituted.
After eight months of treatment and disease 
remission, the patient was presented with neck and 
submandibular pain. A large painful subcutaneous mass 
was found; cytology showed poorly diferentiated cells 
with anisocytosis, polychromasia, macronucleosis and 
macrocariosis. No further tests were performed, and 
the dog was euthanised.
Case 2. Milagros, a mongrel female dog ap-
proximately two years of age, rescued from a shelter, 
was presented after treatment with prednisolone (Ora-
pred®)5 1 mg/kg for skin lesions prescribed by a general 
practitioner. The owner reported a slight improvement 
of the skin lesions at the beginning of the treatment 
three weeks before.
Physical examination showed facial alopecia, 
erythema and scarring of the periocular skin, crusting 
and scaling in alopecic areas, pinnae tip necrosis and 
crusting, ear alopecia (Figure 2A, B), tail tip necrosis 
and crusting. Also present were distal limb alopecia, 
crusting and ulcers in areas of trauma in the hock and 
carpal surfaces; some nails presented onychorhexis 
and onychoschizia.
Skin cytology was performed from the lesions, 
demonstrating non-degenerate neutrophils and nucle-
ated keratinocytes. No microorganisms were found 
on cytology; a fungal culture was negative after 21 
days. Skin biopsies were performed by the previous 
treating veterinarian showing inconclusive results, 
but the report was not made available to us. A CBC 
and blood chemistry showed normal parameters. The 
owners refused a second biopsy. Treatment with pent-
oxifylline (Elorgan®)2 was initiated and the prednisone 
(Meticorten®)3 dose increased to 2 mg/kg SID; sun 
avoidance was recommended.
After 30 days, a marked improvement was 
shown and so the therapy and prednisone was tapered. 
The lowest prednisone (Meticorten®)3 dose without 
skin lesion recurrence was 1 mg/kg SID; azathioprine 
therapy was added to enable lowering the steroids 
needed for remission. The patient has been treated for 
12 months with a good clinical outcome, with pent-
oxifylline (Elorgan®)2, azathioprine (Imuran®)4 2.2 mg/
kg EOD alternating with prednisone (Meticorten®)3 1 
mg/kg EOD. Attempts to stop the steroid therapy were 
unsuccessful due to the lesions relapsing. The CBC 
and chemistry values are monitored every eight weeks. 
The patient is doing well at the writing of this article.
Case 3. Chuchito, an 11-month-old male 
mongrel rescued dog had been previously hospitalised 
due to his skin condition, and treated for mange with 
oral and injectable ivermectins (unknow dose and 
trademark) for three months, amitraz (Tactic®)6 dips 
and oral cephalexin (Keflex®)1 for 6 weeks by the 
referring veterinarian. No improvement was observed 
during this period.
Physical examination showed depigmented 
and alopecic areas in the nasal planum, perioral and 
periocular areas, and inflammation of the palpebral 
tissues (Figure 3A, B). Necrosis of the distal pinnae, 
alopecia and scales were evident (Figure 3C), along 
with sloughing of scales and ulcers. Skin lesions were 
also present in the distal limbs, and alopecia, erythema 
and some crusting and scales in the carpal, tarsal and 
digital areas (Figure 3D). Onychodystrophy was pres-
ent in several digits. Skin cytology was unremarkable, 
and the fungal cultures were negative after 21 days, 
skin scrapings were negative.
Orthopaedic radiographs of the hip and hind 
limbs were performed that revealed proximal femoral 
Figure 2. Facial alopecia, erythema and scarring of the periocular skin 
(A), crusting and scaling in alopecic areas (B), pinnae tip necrosis and 
crusting, ear alopecia.
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head and neck angular deformities. The right femur 
showed coxa-valga (femoral neck to proximal femoral 
shaft angle > 125 degrees and a left femur showed 
coxa-vara (femoral neck to proximal femoral shaft 
angle > 125 degrees) with secondary deformities of the 
proximal tibiae, more prominent on the right side. The 
right patella was slightly displaced laterally. No exact 
origin was determined but was believed to be either 
congenital or developmental. The abnormal proximal 
right hip angle probably affected the position of the 
right patella and was also likely to have contributed 
to the proximal deformities of the tibia.
The CBC, and blood chemistry were all within 
the normal range. Skin biopsies were taken from facial 
area in three different areas. The results are as follows: 
Superficial hair follicles are moderately hyperplastic 
and filled with compact keratin; very few hair shafts 
are present. Follicular growth activity is markedly 
reduced; most of the follicles are in telogen phase. 
Sebaceous gland lobules show variable atrophy and 
squamous metaplasia. Sweat glands are lined by flat-
tened epithelium and contain inspissated secretory 
product. Dermal collagen bundles have a smudgy ap-
pearance, and there is mild dermal mucin deposition. 
The dermis has a mild, interstitial and periadnexal 
infiltrate comprising lymphocytes, pigmented mac-
rophages and fewer neutrophils. No etiologic agents 
areobserved with routine histologic stains. Diagnosis: 
chronic ischaemic dermatopathy.
Treatment was initiated with prednisone (Meti-
corten®)3 2.2 mg/kg day and pentoxifylline (Elorgan®)2 
25 mg/kg BID. The patient developed a cough and 
diarrhea one week after treatment and so therapy was 
halted for 3 weeks during treatment for the respira-
tory condition. After the patient improved, treatment 
was re-initiated. Skin lesions improved partially but 
the owners noticed intense itching. Treatment options 
were discussed and changes were made; pentoxifyl-
line (Elorgan®)2 was continued at the same dosage, 
doxycycline (Vibramicina®)7 100 mg BID, niacinamide 
(Niacin®)8 500 mg, and oclacitinib (Apoquel®)9 0.4 mg/
kg SID were initiated. After 8 weeks of therapy, the dog 
showed marked hair growth, nail quality improvement 
and no more active skin lesions. Solar exposure has 
not been limited and pigmentation is very noticeable 
in the alopecic areas.
DISCUSSION
Dermatomyositis may develop in any breed, 
including mongrel dogs; however, a genetic base 
has been demonstrated in certain breeds: Terveuren, 
Shetland sheepdog, Beauceron, and Portuguese wa-
ter dog [2,13], it is commonly manifested in young 
dogs in a very mild and self-limiting presentation, 
having spontaneous remissions after a few weeks. 
Disease progression may extend for months or years 
or throughout the dog’s life [1,11]. In a study per-
formed of 200 cases of inflammatory myopathy, the 
age ranged from 2 months to 14 years and no sex 
preference was found [4].
The most common initial signs of the disease 
are erythema, desquamation and alopecia in the facial 
area, ears, distal limbs and pinnae in young puppies 
aged between two and six months of age [5], followed 
by pigmentary changes [15]. Muscular lesions are 
uncommon; when present, they represent the most 
severe form of this disease. Dysphagia is a common 
sign and mega-oesophagus may be present. Patients 
with muscular disease can manifest difficulty walk-
ing, with a stiff high gait [3,4,12].
Figure 3. Depigmented and alopecic areas in the nasal planum, perioral 
and periocular areas, and inflammation of the palpebral tissues (A, B). 
Necrosis of the distal pinnae (C), skin lesions in the distal limbs, and 
alopecia, erythema and some crusting and scales in the carpal, tarsal and 
digital areas (D).
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The immune mediated pathogenesis of der-
matomyositis can relate to triggering factors in some 
dogs, such as drugs, infections, paraneoplasms, or 
toxins. Other potential inducing stressors include 
oestrus, whelping and excessive solar exposure [11].
Dermatomyositis-like or familiar dermatomyo-
sitis is diagnosed using clinical findings, histopathol-
ogy of skin and muscle, and muscle physiology studies. 
Electromyography, breed predisposition and genetic 
background can be helpful in some cases [11,13].
The most interesting aspect of these cases 
is that all 3 dogs are mongrels or mixed breed, and 
all 3 are rescued. It is important to point out that, in 
central Mexico, there are no reported cases of leish-
mania which would be a differential diagnosis. As in 
many countries, economical resources are limited for 
diagnostic procedures in rescue groups, which was 
a problem we encountered treating these patients; 
electromyography was not available to our patients at 
the time of diagnosis. It could be argued that there are 
other potential diagnoses for these patients, such as 
vasculitis, vaccine-induced ischaemic dermatopathy, 
drug reactions, and other immune mediated diseases. 
All forms of ischaemic dermatopathy are character-
ised clinically by variable alopecia, erosions, ulcers, 
crusts, and hyperpigmention in a focal or multifocal 
distribution. Lesions can be localised to the dorsal in-
terscapular region, as seen in post-rabies vaccination 
alopecia, or may multifocally involve the face, pinnae, 
foot pads, skin overlying boney prominences, and tip 
of the tail, as seen in DM and idiopathic ischaemic 
dermatopathy [14].
All patients showed very similar skin lesions 
with almost identical patterns (facial alopecia, crust-
ing, ulceration and necrosis of pinnae, tail tip necrosis, 
distal limb skin lesions and nail involvement); in all 
three patients, solar radiation worsened the skin lesions, 
and two of the three cases had nail disease similar to 
that described in humans [9]. Histopathology aided the 
diagnosis in the two cases in which it was performed.
The first case, “Mandarino”, was most se-
verely affected and had the most dramatic improve-
ment. The course of the disease was longer; there 
was muscular involvement, extensive scarring in the 
facial area and lagophthalmia due to eyelid scarring, 
the gums and teeth were also exposed because of lip 
scarring. This patient also developed aspiration pneu-
monia which we related to dysphagia. Once the skin 
lesions had gone into remission, the patient gained 
weight and blood parameters returned to normal. 
Unfortunately, this patient developed a malignancy 
that could have caused the immune mediated disease.
The last case, “Chuchito”, was a young dog 
and the presentation was more typical. The cause of 
his limb deformity was not established, but a nutri-
tional and developmental disorder was suspected. 
Interestingly, in this patient the treatment was not 
typical: steroids were not useful; he presented re-
spiratory infections and gastrointestinal problems 
while on prednisone, so a doxycycline/niacinamide 
combination was used. This combination therapy 
has a immune-modulating effect that, combined with 
pentoxifylline, was very helpful in managing his skin 
lesions. However, itching (this has been reported in 
patients with dermatomyositis) was not controlled 
and oclacitinib was used successfully to inhibit it and 
make him more comfortable.
In conclusion, all three patients eventually re-
sponded well to treatments, but the first and third were 
more susceptible to steroid side effects; pentoxifylline 
was used in all three patients throughout the treatment 
process, and we believe that it was beneficial to all 
of them. Pentoxifylline is considered to be the best 
treatment for DM symtoms, but this depends on the 
severity of the disease. In these cases, we considered 
that this drug alone would not have been enough to 
manage the disease.
Azathioprine can be used safely in many pa-
tients with immune mediated diseases but monitoring 
of these patients is important. A calculated dose of 
azathioprine, using the body mass scale, is more ef-
fective and safer than a standard dose.
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